Ask HopeStage to review this study with me
Study ID: NCT06651411. We help you review the study, but cannot decide medical eligibility.
Active Not RecruitingNCT06651411
The Feasibility of Chatbot-based Stress Management Intervention STARS for Youth in Lithuania
This study is active but not recruiting. It focuses on depression and currently lists study information in Lithuania.
Depression, AnxietyBehavioralFrom 18 Years to 25 Years
Key information made simple
This study is looking at whether psychoeducation can help people with Symptoms of Depression and Anxiety. Participants take part in psychoeducation and complete follow-up assessments. Some participants may receive Control group instead of the study treatment, and direct benefit is not guaranteed.
Your next step
The official record suggests in-person participation through a university, with sites including Vilnius University. Participation appears to involve guided sessions or support activities with check-ins on how they fit into daily life. The main fit is usually having access to the required digital tools and meeting the main study requirements, while common reasons not to take part include safety concerns that need urgent care first and active substance or alcohol problems that could affect the results. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateStarted: October 30, 2024
- Recruitment status
- Active Not Recruiting
- Estimated enrollment
- Not clearly listed
- Sponsor
- Vilnius University
- Sponsor type
- University
- Study type
- Behavioral
- Intervention type
- Behavioral / psychological / psychosocial
- Study phase
- Not clearly listed
- Locations
- Lithuania
- Age range
- From 18 Years to 25 Years
- Official registry ID
- NCT06651411
- Official source
- Official registry link
Want help reviewing this study?
Study ID: NCT06651411. We help you review the study, but cannot decide medical eligibility.
Key study information
- Official title
- The Feasibility of Chatbot-based Stress Management Intervention STARS for Youth in Lithuania
- Condition
- Depression, Anxiety
- Study status
- Active Not Recruiting
- Sponsor / lead affiliation
- Vilnius University
- Location / country
- Lithuania
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT06651411
Why this study may matter
This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
For you
Taking part may help test a support approach in real life.
It requires regular follow-up, often through questionnaires or interviews.
Requires travel, with in-person participation in Lithuania.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring digital app or tool for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. It includes a comparison with a control group. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
What is a behavioral study?
This appears to be a behavioral / psychological / psychosocial study. Phase is mainly useful to check for medication studies and some device studies.
Do I need to want to stop or reduce tobacco use to participate?
The public registry appears to mention tobacco, nicotine, alcohol, cannabis, or another addiction-related topic. Ask the study team whether you need to want to stop, reduce, already be abstinent, or simply meet use-related criteria. Eligibility must be confirmed by the study team.
What would I likely need to do?
You may take part in sessions or exercises related to habits, thoughts, emotions, or behaviors. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
Could this study affect my mood, habits, motivation, or stress?
Behavioral studies can involve habits, emotions, motivation, stress, sleep, or ways of thinking. Ask whether the intervention could affect your mood or stress, and who to contact if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Vilnius University, which appears to be a university. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The registry indicates that the study is active but not currently recruiting. This usually means participants may already be involved, but new participants may not be accepted.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meOther studies you may want to explore next
RecruitingNCT06966401
NBI-1065845 for depression
This study is recruiting in the United States, in the United Kingdom, in Belgium, .... It is testing NBI-1065845 for depression.
RecruitingNCT05850689
Lumateperone as Adjunctive Therapy in the Treatment of people with Major Depressive Disorder
This study is recruiting. It focuses on depression and currently lists participation information in Bulgaria, France, India, Lithuania, Serbia, Spain, and the United States.
RecruitingISRCTN12329547
study of a digital depression management application: juli
This study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom, Afghanistan, Finland, Albania, Algeria, the United States, Andorra, Angola, Antarctica, Antigua and Barbuda, Argentina, Armenia, the Netherlands, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Norway, Brazil, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cabo Verde, Cambodia, Cameroon, Canada, Central African Republic, Chad, Chile, China, Colombia, Comoros, Congo, Congo, Democratic Republic, New Zealand, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Côte d'Ivoire, Denmark, Djibouti, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Eswatini, Ethiopia, Fiji, France, Gabon, Gambia, Georgia, Germany, Ghana, Greece, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Vatican City, Honduras, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, North Korea, South Korea, Kosovo, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Latvia, Lebanon, Lesotho, Liberia, Libya, Liechtenstein, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Mexico, Micronesia, Federated States of, Moldova, Monaco, Mongolia, Montenegro, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Nicaragua, Niger, Nigeria, North Macedonia, Oman, Pakistan, Palau, Palestine, State of, Panama, Papua New Guinea, Paraguay, Peru, the Philippines, Poland, Portugal, Qatar, Romania, Russian Federation, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, South Sudan, Spain, Sri Lanka, Sudan, Suriname, Sweden, Switzerland, Syria, Taiwan, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tonga, Trinidad and Tobago, Tunisia, Turkmenistan, Tuvalu, Turkey, Uganda, Ukraine, United Arab Emirates, Uruguay, Uzbekistan, Vanuatu, Venezuela, Vietnam, Western Sahara, Yemen, Zambia, and Zimbabwe.